NEW YORK – Solvd Health said on Wednesday that it is preparing to launch a prospective US clinical trial of its noninvasive colorectal cancer screening test, LifeKit Prevent.
The assay is being developed in partnership with Metabiomics, a subsidiary of the Carlsbad, California-based firm. It is an in vitro diagnostic test that uses Metabiomics' MultiTag DNA sequencing technology to detect and analyze microbial genomic biomarkers in human stool samples that are strongly associated with specific stages of CRC progression.